Skip to main content

Featured Stories

News
April 13, 2021
According to study findings published online in Cancer Chemotherapy and Pharmacology, researchers identified the optimal dose of selinexor in patients with diffuse large B-cell.
News
April 12, 2021
According to a cross-sectional study, patients with non-radiographic axial spondyloarthritis at moderate risk of cardiovascular disease per the…
Interview
April 12, 2021
Jenn Zerbato, PhD, post-doctoral research fellow, Peter Doherty Institute for Infection and Immunity, breaks down why HIV RNA could serve as a better…
Interview
April 07, 2021
Anthony Costello, president of Patient Cloud at Medidata, discusses challenges facing clinical trials with regard to sensor and data usage, and…
News
April 07, 2021
For the treatment of moderate-to-severe atopic dermatitis, biologics with the most robust efficacy and safety evidence are dupilumab, baricitinib,…
Formulary Frontlines
April 06, 2021
"Seeing first-hand the aggressive nature of SCLC and knowing that the large majority of those diagnosed will experience relapse, I am excited to see…
Interview
April 06, 2021
Shephard Mpofu, MD, senior vice president and chief medical officer, Novartis Gene Therapies, discusses various trials—SPR1NT, LTFU, and RESTORE from…
News
April 01, 2021
Many officials are concerned that Blue Shield's take over of the vaccination program will cause health care workers to waste valuable time learning…
News
March 31, 2021
“Costs likely vary substantially between institutions and practices, but our data suggest that even with an efficient, dedicated prior authorization…
Back to Top